Earningsreport

Q1/2024 3/31/2024 EPS -0.250 ZacksConsensus -0.300 ActVsEst 0.050 - Beat

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases